Efficacy of two ovarian stimulation drugs(Menotropin versus Menotron) on IVF/ ICSI cycles outcomes

Phase 2

• Conditions: Condition 1: Anovulation infertility. Condition 2: Tubal female inferility. Condition 3: Unexplained infertility. Condition 4: Male infertility.; Female infertility associated with anovulation; Female infertility of tubal origin; Female infertility, unspecified; Male infertility

• Registration Number: IRCT2016102118662N3
• Lead Sponsor: Avicenna Infertility Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

age: 19-38 years old; FSH<10; infertility due to male factor, mild pco, tubal factor, unexplained factor.
Exclusion criteria: 3 or more failed IVF/ICSI cycle; poor ovarian responders; utilization of donation systems; uncontrolled diseases such as Diabetes, HTN, Lupus, Renal failures,...; anatomical abnormalities( congenital, submucosal myoma, Asherman syn,...); endometriosis grade 3, 4 and BMI>=35.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ICSI Outcome(chemical pregnancy). Timepoint: Two weeks afert embryo transfer. Method of measurement: Serum Beta HCG.;Clinical pregnancy. Timepoint: Three weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.

Secondary Outcome Measures

Name	Time	Method
Oocyte quality. Timepoint: On the oocyte collection day. Method of measurement: Morphologic assesment with microscope.;Embryo quality. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: Morphologic assesment with microscope.;Fertilization rate. Timepoint: 2 or 3 days after oocyte collection. Method of measurement: (embros number/injected oocytes numbers) * 100.